Adenosine: an old drug newly discovered.

作者: Holger K. Eltzschig , David S. Warner , Mark A. Warner

DOI: 10.1097/ALN.0B013E3181B060F2

关键词: AdenosineExtracellularLung injuryAdenosine receptorMedicineCardiovascular agentSignal transductionPurinergic signallingPharmacologyAdenosine A3 receptor

摘要: Over decades, anesthesiologists have used intravenous adenosine as mainstay therapy for diagnosing or treating supraventricular tachycardia in the perioperative setting. More recently, specific receptor therapeutics gene-targeted mice deficient extracellular production individual receptors became available. These models enabled physicians and scientists to learn more about biologic functions of nucleotide metabolism signaling. Such include signaling effects through expressed by many mammalian tissues; example, vascular endothelia, myocytes, hepatocytes, intestinal epithelia, immune cells. At present, pharmacological approaches modulate are evaluated their potential use medicine, including attenuation acute lung injury; renal, intestinal, hepatic myocardial ischemia; leakage. If these laboratory studies can be translated into clinical practice, receptor-based may become an integral component daily anesthesiology practice.

参考文章(128)
Etienne Delacrétaz, Supraventricular Tachycardia New England Journal of Medicine. ,vol. 354, pp. 1039- 1051 ,(2006) , 10.1056/NEJMCP051145
Holger K. Eltzschig, Thomas Weissmüller, Alice Mager, Tobias Eckle, Nucleotide metabolism and cell-cell interactions. Methods of Molecular Biology. ,vol. 341, pp. 73- 87 ,(2006) , 10.1385/1-59745-113-4:73
Nancy A. Louis, Andreas M. Robinson, Christopher F. MacManus, Jörn Karhausen, Melanie Scully, Sean P. Colgan, Control of IFN-αA by CD73: Implications for Mucosal Inflammation Journal of Immunology. ,vol. 180, pp. 4246- 4255 ,(2008) , 10.4049/JIMMUNOL.180.6.4246
Catherine Ledent, Jean-Marie Vaugeois, Serge N. Schiffmann, Thierry Pedrazzini, Malika El Yacoubi, Jean-Jacques Vanderhaeghen, Jean Costentin, John K. Heath, Gilbert Vassart, Marc Parmentier, Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor Nature. ,vol. 388, pp. 674- 678 ,(1997) , 10.1038/41771
Melanie L. Hart, Barbara Jacobi, Jens Schittenhelm, Martina Henn, Holger K. Eltzschig, Cutting Edge: A2B Adenosine Receptor Signaling Provides Potent Protection during Intestinal Ischemia/Reperfusion Injury Journal of Immunology. ,vol. 182, pp. 3965- 3968 ,(2009) , 10.4049/JIMMUNOL.0802193
Keiichi Enjyoji, Jean Sévigny, Yuan Lin, Paul S. Frenette, Patricia D. Christie, Jan Schulte Am Esch, Masato Imai, Jay M. Edelberg, Helen Rayburn, Miroslaw Lech, David L. Beeler, Eva Csizmadia, Denisa D. Wagner, Simon C. Robson, Robert D. Rosenberg, Targeted disruption of cd39 /ATP diphosphohydrolase results in disordered hemostasis and thromboregulation Nature Medicine. ,vol. 5, pp. 1010- 1017 ,(1999) , 10.1038/12447
Julia-Stefanie Frick, Christopher F. MacManus, Melanie Scully, Louise E. Glover, Holger K. Eltzschig, Sean P. Colgan, Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. Journal of Immunology. ,vol. 182, pp. 4957- 4964 ,(2009) , 10.4049/JIMMUNOL.0801324
Yuan-Ji Day, Liping Huang, Hong Ye, Li Li, Joel Linden, Mark D. Okusa, Renal Ischemia-Reperfusion Injury and Adenosine 2A Receptor-Mediated Tissue Protection: The Role of CD4+ T Cells and IFN-γ Journal of Immunology. ,vol. 176, pp. 3108- 3114 ,(2006) , 10.4049/JIMMUNOL.176.5.3108
Jonathan B. Volmer, Linda F. Thompson, Michael R. Blackburn, Ecto-5'-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. Journal of Immunology. ,vol. 176, pp. 4449- 4458 ,(2006) , 10.4049/JIMMUNOL.176.7.4449